Surge of generic weight-loss drugs triggers price war in India [Globe and Mail, The (Toronto, Canada)]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Globe and Mail, The
A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost generic versions. INDRANIL MUKHERJEE/AFP/Getty Images Industry estimates suggest that more than 50 low-cost versions are set to be rolled out in the coming weeks. Several are already available in retail pharmacies at prices 60 per cent to 90 per cent lower than those of international brands, prompting Novo Nordisk to cut prices of Ozempic and Wegovy in India by 36 per cent to 48 per cent this week. Generic Ozempic makes debut in India – ahead of Canada, where it became legal months ago Manufacturers have been barred from direct-to-consumer advertising, including surrogate and influencer-led promotion, although anti-obesity media campaigns have surfaced. The Drugs Controller General of India, along with state controllers, has stepped up surveillance of the unauthorized sale and promotion of GLP-1 drugs through retail pharmacies, online platforms, wholesalers
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk: Downgrading To 'Sell' As GLP-1 Pipeline Faces Many Risks [Seeking Alpha]Seeking Alpha
- Aspect Biosystems receives funding for cellular medicine project [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk CEO says weight-loss drug boom has barely begun [Seeking Alpha]Seeking Alpha
- Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight [Yahoo! Finance]Yahoo! Finance
- Asian travelers seek respite in other options as Middle East travel plans stay grounded Share Share VIDEO 9:54 09:54 How will Middle East flight disruptions and FX moves affect tourism in Asia? [CNBC]CNBC
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/30/26 - Form 6-K
- 3/27/26 - Form 6-K
- 3/27/26 - Form 6-K
- NVO's page on the SEC website